Life Sciences & Pharma Royalty Financing Comes of Age: Why This Once-Niche Source of Capital Is Gaining Momentum April 17, 2026
Life Sciences & Pharma Modular Medicines: Combinatorial Modularity as a Strategic Source of Innovation April 14, 2026
Life Sciences & Pharma A Bifurcated Lab Market Is Reshaping Strategic Priorities and Capital Decisions February 27, 2026
Financial Services P&C Commercial Lines Distribution Reinvented: Why Legacy Strategies Won’t Win the Next Cycle February 03, 2026
Life Sciences & Pharma From Discovery to Launch: Building Next-Generation Investment Governance for Biotech January 13, 2026
Healthcare Services Unlocking Deal Value: How Operational Due Diligence Shapes a Feasible, High-Impact Value Creation Strategy January 12, 2026